With its complex structure and the breadth of ocular disorders, the eye presents unique challenges to drug discovery. Cambridge Healthtech Institute’s fourth annual Targeting Ocular Disorders conference provides a platform to discuss novel targets and disease pathways, the latest drug delivery methods, and the most promising emerging therapies. A special focus will be on gene therapy, stem cell therapies, and treatments outside of the well-established anti-VEGF therapies. The event will cover a broad range of diseases including but not limited to glaucoma, wet and dry age‐related and diabetic macular degeneration, retinopathy and retinitis pigmentosa.

Who should attend: Directors, Managers, Researchers, and Scientists from Pharma, Biotechs, Academia, Government and Healthcare Organizations working in the area of ophthalmology

Topics will include, but are not limited to:

  • Gene therapy for retinal diseases
  • Stem cell trials in the back of the eye
  • Drug delivery methods for ocular disorders (microneedles, micro- and nano-particles, intraocular sustained drug delivery device, etc.)
  • Targeting existing pathways in new ways
  • Sustained release anti-VEGF therapies and anti-VEGF combo therapies
  • Small molecules for eye disease
  • Novel targets and disease pathways (anti-PDGF, Tie 2 inhibition, angiopoetins, kallikreins, interleukins, microRNA inhibitors)
  • Clinical trials and promising drugs in the pipeline for common and rare/orphan ocular disorders: wet and dry Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), glaucoma, diabetic retinopathy, retinitis pigmentosa

If you are interested in speaking, please click here.

Click here to register for a special early-bird discounted rate.

The deadline for submission is March 4, 2016.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For questions or suggestions about the meeting, please contact:
Lee Yuan
Conference Director
Cambridge Healthtech Institute
T: (+1) 781-972-5404
E: lyuan@healthtech.com

For sponsorship and exhibit sales information including sponsored podium presentations, contact:
Jon Stroup
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com